Insider Trading Arrangements

3 Months Ended

Mar. 31, 2026

From time to time, our officers (as defined in Rule 16a–1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months ended March 31, 2026, our officers and directors took the following actions with respect to 10b5-1 trading arrangements:

Trading Arrangement

Name (Title)

Action

Date

Type of Trading Arrangement

Nature of Trading Arrangement

Aggregate Maximum Number of Shares that may be Sold

Expiration Date

Natarajan Sethuraman (President of Research and Development)

Adopt

3/2/2026

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)

Sale of the Company's common stock pursuant to the terms of the plan

120,879(1)

5/31/2027

Kory Wentworth (Chief Financial Officer)

Adopt

3/11/2026

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)

Sale of the Company's common stock pursuant to the terms of the plan

44,356(1)

6/1/2027

Dipal Doshi (Chief Executive Officer)

Adopt

3/13/2026

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)

Sale of the Company's common stock pursuant to the terms of the plan

12,000(2)

6/1/2027

(1)For purposes of this disclosure, the shares included in this table reflect the aggregate maximum number of shares that may be sold under the 10b5-1 trading arrangements. These 10b5-1 trading arrangements cover RSUs, shares underlying stock options exercisable and shares held by the officers. The actual number of shares that may be sold under the 10b5-1 trading arrangements will be calculated as RSU vesting to satisfy tax withholding obligations pursuant to the Company’s non-discretionary sell-to-cover requirement occurs.

(2)For purposes of this disclosure, the shares included in this table reflect the aggregate maximum number of shares that may be sold under the 10b5-1 trading arrangement.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Natarajan Sethuraman [Member]

Trading Arrangements, by Individual

Name

Natarajan Sethuraman

Title

President of Research and Development